Lymphedema Completed Phase 2 Trials for Ubenimex (DB03424)

Also known as: Lymohedema / Lymphoedema / Lymphoedemas / Lymphoedema NOS

IndicationStatusPhase
DBCOND0029071 (Lymphedema)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02700529Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)Treatment